药品名称 | APRESOLINE | 申请号 | 008303 | 产品号 | 001 | 活性成分 | HYDRALAZINE HYDROCHLORIDE | 市场状态 | 停止上市 | 剂型或给药途径 | TABLET;ORAL | 规格 | 25MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons** | 治疗等效代码 | | 参比药物 | 否 | 批准日期 | Approved Prior to Jan 1, 1982 | 申请机构 | NOVARTIS PHARMACEUTICALS CORP
| 化学类型 | New molecular entity (NME) | 审评分类 | Priority review drug |
|
|
与本品相关的专利信息(来自橙皮书Orange Book) | 专利号 | 专利过期日 | 是否化合物专利 | 是否产品专利 | 专利用途代码 | 专利下载 | 无 | 历史专利信息 | 无 |
|
与本品相关的市场独占权保护信息 | 独占权代码 | 失效日期 | 无 | 历史市场独占权保护信息 | 无 |
|
与药品注册相关的信息 | 申请号 | 修订号 | 审批结论 | 公开文档类型 | 文档创建时间 | 获取文档 | 008303 | 068 | AP | Label | 2008/01/22 | 下载 |
|
药品注册审批历史信息 | 申请号 | 修订号 | 审批结论 | 审批日期 | 审批内容 | 008303 | 071 | AP | 1999/04/28 | Package Change | 008303 | 070 | AP | 1997/02/03 | Control Supplement | 008303 | 069 | AP | 1996/08/22 | Manufacturing Change or Addition | 008303 | 068 | AP | 1996/02/28 | Labeling Revision | 008303 | 067 | AP | 1994/07/12 | Control Supplement | 008303 | 066 | AP | 1993/12/27 | Control Supplement | 008303 | 065 | AP | 1992/01/03 | Control Supplement | 008303 | 064 | AP | 1991/08/05 | Manufacturing Change or Addition | 008303 | 063 | AP | 1991/06/19 | Control Supplement | 008303 | 062 | AP | 1989/03/07 | Labeling Revision | 008303 | 059 | AP | 1986/12/22 | Labeling Revision | 008303 | 058 | AP | 1985/09/13 | Labeling Revision | 008303 | 057 | AP | 1985/03/19 | Control Supplement | 008303 | 055 | AP | 1984/09/18 | Package Change | 008303 | 053 | AP | 1983/12/15 | Formulation Revision | 008303 | 052 | AP | 1983/11/15 | Formulation Revision | 008303 | 050 | AP | 1983/07/15 | Package Change | 008303 | 049 | AP | 1982/08/23 | Manufacturing Change or Addition | 008303 | 048 | AP | 1982/05/05 | Package Change | 008303 | 047 | AP | 1985/04/18 | Practioner Draft Labeling | 008303 | 046 | AP | 1981/02/27 | Labeling Revision | 008303 | 045 | AP | 1980/05/08 | Labeling Revision | 008303 | 044 | AP | 1980/01/25 | Package Change | 008303 | 043 | AP | 1979/07/31 | Package Change | 008303 | 042 | AP | 1979/08/02 | Package Change | 008303 | 041 | AP | 1979/05/29 | Control Supplement | 008303 | 040 | AP | 1979/04/09 | Package Change | 008303 | 039 | AP | 1979/04/09 | Package Change | 008303 | 038 | AP | 1979/04/09 | Package Change | 008303 | 037 | AP | 1979/10/04 | Labeling Revision | 008303 | 036 | AP | 1979/10/04 | Labeling Revision | 008303 | 033 | AP | 1977/09/07 | Control Supplement | 008303 | 032 | AP | 1977/12/08 | Package Change | 008303 | 031 | AP | 1977/04/18 | Formulation Revision | 008303 | 029 | AP | 1977/04/18 | Labeling Revision | 008303 | 027 | AP | 1977/04/18 | Formulation Revision | 008303 | 025 | AP | 1977/07/11 | Package Change | 008303 | 024 | AP | 1976/04/19 | Labeling Revision | 008303 | 023 | AP | 1977/07/11 | Labeling Revision | 008303 | 021 | AP | 1977/07/11 | Supplement | 008303 | 000 | AP | 1953/01/15 | Approval |
|